Concepedia

Kent Iverson

KI

Statistics

Publications

2

Citations

38

H-Index

2

Active since

2013

Affiliations

Acumen Pharmaceuticals (United States)(Current)

Kent Iverson is an author at Acumen Pharmaceuticals (United States) specializing in molecular biology, alzheimer's disease, and immunology.

Top concepts

Publications per year

2013–2022

2

Publications

2

ACU193, a Monoclonal Antibody that Selectively Binds Soluble Aβ Oligomers: Development Rationale, Phase 1 Trial Design, and Clinical Development Plan

Eric Siemers, J. Hitchcock, Karen L Sundell et al. · The Journal of Prevention of Alzheimer s Disease · 2022 · 25 citations · Full text

O2–06–03: ACU‐193: A candidate therapeutic antibody that selectively targets soluble beta‐amyloid oligomers

Grant A. Krafft, Franz Hefti, William F. Goure et al. · Alzheimer s & Dementia · 2013 · 13 citations · Full text

, , +15

1–2 of 2